PCF Webinar Series for Patients & Families
PCF aims to connect patients and caregivers with current, essential information across the various stages of the prostate cancer journey. Leaders in the field of prostate cancer discuss key topics in diagnosis, treatment, research, and survivorship and answer your questions during these live virtual events.
Webinars are FREE and open to ALL.
PCF thanks our supporters who help make these events possible.
November 18, 2024: Immunotherapy for Prostate Cancer: What’s Now, What’s Next
Time: 4:30 PM Pacific / 7:30 PM Eastern
While patients with advanced prostate cancer have many options to help manage the disease, more treatments are urgently needed. Harnessing a patient’s immune system to kill prostate cancer cells is one approach.
Learn about your immune system, the connection to prostate cancer, available treatments, and the future of this exciting field. PCF-funded Young Investigator Nicholas Zorko, MD, PhD of the University of Minnesota hosts a discussion with Neeraj Agarwal, MD, of the Huntsman Cancer Institute, University of Utah, and Sumit K. Subudhi, MD, PhD, of MD Anderson Cancer Center. We’re honored that a patient successfully treated through immunotherapy will join us to share his experiences.
Special thanks to Dendreon and Exelixis for their support of this program.
September 12, 2024: Heart Health During and After Prostate Cancer
Whether you’ve had prostate cancer and have been successfully treated for it, or you’re in treatment for advanced disease… don’t forget about the rest of your body, especially, your heart. Good news: there’s a lot you can do to power up your heart health, starting with awareness.
Zachary Klaassen, MD, MSc, of Wellstar MCG Health hosts a discussion with his colleague, cardio-oncologist Avirup Guha, MBBS, MPH and June Chan, ScD of UCSF. Learn how to work with your treatment team to lower your risk and boost your overall wellness, and get the latest on science-backed nutrition and exercise for people with prostate cancer.
May 20, 2024: How Oncology Nurses and Social Workers Can Help You Navigate Your Care
Medical oncologist Alicia Morgans, MD, MPH, Medical Director of the Survivorship Program at Dana Farber, hosts a discussion with her team members: nurse practitioner Stacy Walker, CNP, and social worker Max McMahon, LICSW. Learn who’s on your team, and how they handle the most common and challenging questions, including medications, side effects, financial resources, and finding a second opinion.
March 12, 2024: Advanced Prostate Cancer Series: PSMA-Targeted Therapies
Patients with advanced prostate cancer have many treatment options, but more alternatives are urgently needed. PSMA (Prostate Specific Membrane Antigen) is a molecule that sits on the surface of prostate cancer cells and is used as a target for treatment. Host Dr. Oliver Sartor (Mayo Clinic) speaks with Dr. Louise Emmett (University of New South Wales) and Dr. Michael Morris (Memorial Sloan Kettering Cancer Center). Learn about the current state of PSMA-targeted therapies as well as what’s on the horizon.
January 16, 2024: Prostate Cancer Screening: What Men & Families Need to Know
Prostate cancer screening has been fraught with myths, challenges, and controversies over the years. Men and their families, and even some health care providers, are unsure about what the “gold standard” of screening is. At what age should I start? How do I bring this up with my doctor? When should I stop screening? And what about the “finger test”? Dr. William Oh unpacks the confusion with urologic oncologist Dr. Isla Garraway (UCLA & Greater Los Angeles VA) and epidemiologist Dr. Sigrid Carlsson (Memorial Sloan Kettering). If you are living with the disease, consider sharing this webinar with a friend or family member.
December 12, 2023: Guiding Treatment Choices in Localized Prostate Cancer
If you have been diagnosed with localized prostate cancer, how do you and your doctor choose the best therapy? Today, newer forms of testing of your tumor’s genetic material can help you understand more about the aggressiveness of the cancer and guide treatment choice. Host Zachary Klaassen, MD, MSc, leads a discussion with urologist Aditya Bagrodia, MD, FACS, and radiation oncologist Tyler Seibert, MD, PhD, on how they use this approach in caring for patients. Learn about your treatment options, how the results of testing can inform treatment decisions, and what questions to ask your doctor.
This webinar is generously supported by 
November 29, 2023: Advanced Prostate Cancer Series: Metastatic Castration-Resistant Disease
Part 2 of this series covers castration-resistant prostate cancer, in which patients who have taken hormone therapy, or are currently on hormone therapy, see their PSA levels rise, and sites of metastatic cancer are seen on imaging scans. PCF’s Dr. William K. Oh is joined by medical oncologists Dr. Mary-Ellen Taplin (Dana Farber) and Dr. Rana McKay (UCSD) to discuss the many treatment options available today . Learn about the types of testing needed to understand your specific type of cancer, how to select a therapy, the importance of clinical trials, and more.
October 17, 2023: Advanced Prostate Cancer Series: Metastatic Hormone-Sensitive Disease
Metastatic prostate cancer means that the cancer has spread outside the prostate region to other parts of the body. In Part One in a series on advanced and metastatic prostate cancer, this month we focus on “hormone sensitive” disease: the earlier stages, in which patients started on hormone therapy see their PSA drop as the tumor shrinks. PCF Chief Medical Officer Dr. William K. Oh speaks with two highly experienced clinicians in urology and medical oncology. Learn how metastatic hormone-sensitive prostate cancer develops, what your treatment options are, possible side effects, and questions to ask your doctor.
This webinar is generously supported by 
September 26, 2023: Mental and Emotional Wellness in Prostate Cancer
Mental and emotional wellness is vital part of prostate cancer treatment and recovery, but it can be hard to talk about it with your treatment team, family, or friends. PCF CEO Dr. Charles J. Ryan leads a conversation on the emotional health issues patients face, anxiety around PSA levels, stress management, and effects on relationships. “Dr. Drew” Pinsky, MD, is a board-certified physician, addiction medicine specialist, prolific broadcaster, and prostate cancer survivor. Mindy Utay, LCSW, is a licensed psychotherapist with training and expertise in use of stress-reduction strategies.
This webinar is generously supported by
July 18, 2023: All About Hormone Therapy
Hormone therapy is a mainstay of treatment for many patients with prostate cancer. It can extend lives….but can have a wide range of possible side effects. Host Dr. William K. Oh speaks with oncologist Dr. Alicia Morgans and her patient, endocrinologist and prostate cancer survivor Dr. Michael F. Holick. Dr. Morgans reviews the essentials of when and how hormone therapy is used. Dr. Holick shares how he has applied his clinical expertise to understand the effects of hormone therapy on his body and mind, and to develop strategies to address them. Come away with practical tips as well as questions to ask your doctor at your next visit.
This event is generously supported by 
June 28, 2023: Men’s Health Month: The Patient Perspective
In honor of National Men’s Health Month and Pride Month, June’s webinar brings two stories of men and their journeys through and beyond prostate cancer, with host Dr. Zachary Klaassen, a urologic oncologist. Hear from a man who was experiencing symptoms but was unaware that it could be prostate cancer. He shares how meeting Dr. Klaassen made all the difference in his care and his outlook today. Our second speaker participated in a study for gay men following treatment for localized prostate cancer and has been active in gay men’s support groups and advocacy. Urologist Dr. Sherita King discusses the clinical issues she sees in her practice helping men restore sexual function. Drs. Klaassen and King take viewers’ questions about active surveillance, diet, testosterone, and more.
This event is generously supported by
May 16, 2023: Genetic and Biomarker Testing: What Does It Mean for Me?
Genetic testing and biomarker testing can help doctors and patients learn as much as possible about each patient’s prostate cancer. People across all stages of the prostate cancer spectrum may be interested in this topic, from newly-diagnosed patients deciding on a treatment plan, to men with metastatic disease seeking additional treatment options. PCF’s Chief Medical Officer William K. Oh, MD, speaks with two experienced clinicians who are committed to help patients and families understand what these types of testing mean for their care.
Kara Maxwell, MD, PhD (University of Pennsylvania and Corporal Michael Crescenz VA Medical Center) discusses genetic testing.
Jim C. Hu, MD, MPH (Weill Cornell Medicine) discusses biomarker testing and risk stratification.
PCF thanks Veracyte for their generous support
April 25, 2023: Clinical Trials: What to Consider
Clinical trials for prostate cancer play a vital role in getting new treatments into clinical practice. They can offer the potential for life-extending therapy. Patients and families have many questions: Is it safe? What happens during the trial? Can I still see my doctor? Who pays for it? PCF Chief Medical Officer William K. Oh, MD, hosts two leaders in prostate cancer clinical care and research: Isla Garraway, MD, PhD,(UCLA) and Samuel Washington, MD, MAS (UCSF). They’ll explain the process, distinguish fact from fiction, and discuss how clinical trials can better include diverse populations.
March 14, 2023: PSMA PET Imaging: Doctor and Patient Perspectives
PSMA PET is a newer, highly sensitive imaging scan that can detect prostate cancer metastases much earlier, when they are much smaller. Learn when and how PSMA PET is used, what the results mean, what happens during the scan, and more. Dr. Ryan is joined by nuclear medicine expert Dr. Phillip Koo (Banner MD Anderson Cancer Center) as well as Ira and Sharron, a patient and caregiver who will share their experience.
This event is generously supported by
February 21, 2023: Prostate Cancer Disparities: What Men and Families Need to Know
Our series addressing prostate cancer disparities continues with two guests who will distill years of research and clinical experience into practical tips. Dr. John Carpten, PhD (USC) is an expert in prostate cancer genetics, and Dr. Stanley Frencher, MD, is a practicing urologist and Medical Director of Surgical Outcomes and Quality at Martin Luther King, Jr. Community Hospital in Los Angeles. You’ll hear how research is shedding new light on the inheritance of prostate cancer, and why families should be proactive and share knowledge of cancer risk. And if you are diagnosed, learn what you need to know to find a treatment that is right for you, and what questions to ask your provider.
February 8, 2023: Prostate Cancer Disparities: Crucial Conversations
1 in 6 Black men will be diagnosed with prostate cancer in his lifetime, vs 1 in 8 white men. PCF begins a yearlong effort to raise awareness of prostate cancer early detection and screening among minority communities. Dr. Ryan speaks with two leaders who have dedicated their careers to understanding and reducing health disparities: Dr. Michael LeNoir, MD, of the African American Wellness Project and Dr. Leanne Burnham of Morehouse School of Medicine. Learn about the roots of prostate cancer disparities and ways to empower yourself to keep you and your family safe from cancer.
January 17, 2023: When Your PSA is Rising after Treatment
You’ve been through treatment for prostate cancer. Months or years later, you get the news you hoped would never come: your PSA is rising. PCF President and CEO Dr. Charles J. Ryan helps patients navigate this course in his practice as a medical oncologist. His guests will discuss PSA and recurrence from their perspectives as a urologic oncologist (Dr. Ashley Ross of Northwestern Medicine) and a radiation oncologist (Dr. Paul Nguyen of Dana Farber Cancer Institute). Learn about what the numbers mean, testing beyond PSA, and treatment options. Please note that the recordings below focus on post-surgery and post-radiation, respectively, but you may wish to watch both to get a full picture of the topics discussed.
Read the Q&A here.
December 13, 2022: Sexual Health and Incontinence
Changes in urinary and sexual function are two of the most common—and most feared—possible side effects of treatment for localized prostate cancer. Fortunately, there is room for much optimism: there are many excellent options to manage them. Dr. Ryan speaks with urologic surgeon Dr. Sherita King of Augusta University Health and the Medical College of Georgia. She is an expert in male and female sexual dysfunction, and a recognized center of excellence in penile implants. Dr. Lindsay Hampson will discuss management of incontinence. She specializes in genitourinary reconstruction, including complications of surgery and radiation therapy, and is Associate Professor of Urology at UCSF.
October 11, 2022: Shared Decision-Making and Treatment Regret
How do you make decisions about prostate cancer treatment? It can be challenging, at any stage in the journey. Medical oncologist Dr. Alicia Morgans (Dana Farber Cancer Institute) discusses the importance of shared decision-making and practical tips on communicating with your healthcare team. Urologist Dr. Matthew Cooperberg (UCSF) will address a related phenomenon, treatment-related regret.
September 20, 2022: Physical and Mental Wellness in Prostate Cancer
Dr. Stacey Kenfield (UCSF) discusses Prostate 8: Simple Lifestyle Changes That Work and offers practical ways to incorporate nutrition and exercise into your life. Psychiatrist Dr. Andrew Roth (MSKCC) specializes in caring for patients with genitourinary cancers. He will review the mental health challenges patients commonly face, how to help yourself, and how to start the conversation with your doctor.
This event is generously supported by 